Selective activation of ATF-6 in response to CERS6/C16 ceramide down-regulation protects head and neck squamous cell carcinoma cells from ER stress-induced apoptosis by preventing ER/Golgi [Ca2+] depletion and CHOP activation [39]. The gene discussed is ATF6; the disease is head and neck squamous cell carcinoma.